Search results for: 'second and coach'
- Did you mean
- second ad coach
- Related search terms
- AND (SELECT (CASE WHEN (3989=1399) THEN NULL ELSE CTXSYS.DRITHSX.SN(1,3989) END) FROM DUAL) IS NULL
- AND (SELECT (CASE WHEN (4327=4327) THEN NULL ELSE CTXSYS.DRITHSX.SN(1,4327) END) FROM DUAL) IS NULL
- AND (SELECT (CASE WHEN (1509=3753) THEN NULL ELSE CTXSYS.DRITHSX.SN(1,1509) END) FROM DUAL) IS NULL-- wUvH
- AND (SELECT 1827 FROM (SELECT(SLEEP(20)))zydf)
- Second Skin Diagnostics - Innovations and Growth Opportunities
-
31 Dec 2018  |  Asia Pacific  |  Market Research
Malaysian Commercial MRO Market, 2018
Malaysian Commercial MRO Market, the 2nd Largest in Southeast Asia, Hovered at the Billion-dollar Mark in 2018
This study aims to evaluate commercial aircraft fleet and MRO market in Malaysia consisting of current fleet in 2018, segmented on multiple criteria, furthermore focusing on the market trends, technology Mega Trends, and opportunity areas. Among all the Southeast Asian nations, Malaysia is the second largest MRO spender in terms of MRO market size....
$3,000.00
Special Price $2,250.00 save 25 %
-
23 Dec 2019  |  Asia Pacific  |  Market Research
Asia-Pacific Network Security Market Q2 2019 Tracker
Service Provider and Government Sector Remained As the Key Revenue Contributors to Drive the Network Security Market
The Asia-Pacific network security market witnessed a YoY growth of 14.7% in Q2 2019. This was much stronger than the 11.9% YoY in the previous second quarter. In Q2 2019, the healthcare sector was the fastest-growing vertical; it recorded a YoY growth of 26.7%. However, market size of the healthcare sector remained the smallest revenue contributor ...
$1,500.00
Special Price $1,125.00 save 25 %
-
10 Jan 2020  |  Asia Pacific  |  Market Research
Growth Insights on China’s Pharmaceutical Industry, Forecast to 2025
Expedited Regulatory Reviews, Accompanied by Surging Novel Drug Pipelines and a Realigned Distribution System will Propel the Chinese Pharma Industry
With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...
$10,000.00
Special Price $7,500.00 save 25 %